Similar results were observed with signature 3 (Fig. 4), in which two compounds were of negative consequence and increased risk (97) or induced (9) asthma, and eight were of benefit and decreased bronchoconstriction (2, 44, 48, 60, 73) or AHR (37, 76) (Table 3). The gene discussed is AHR; the disease is asthma.